SAPIOME™ helps mature and startup businesses turn complex microbiome and nutrition science into investable R&D strategy, credible clinical programs, and defendable product claims.
Focus areas include nutraceuticals, pre/pro/postbiotics, microbiome-targeted ingredients, and adjacent biotech platforms.
Services
Designed for teams who need senior R&D and clinical strategy without adding another full-time hire, SAPIOME plugs into existing organizations and helps them move faster with less risk.
Structure and prioritize your nutraceutical and biotics roadmap, from early concepts through long-term platform bets, grounded in mechanistic science and commercial relevance.
End-to-end support for selecting investigators and CROs, shaping protocols, and overseeing execution so your trials read out cleanly against meaningful endpoints.
Independent scientific and operational review of proposed clinical work to de-risk design choices before first patient in.
Align in vitro, ex vivo, and in vivo workstreams with how regulators, clinicians, and customers will ultimately evaluate your product.
Build a claims ladder that your evidence can actually support—then iterate as your data matures.
Grow a targeted network of research partners across B2B suppliers, FMCG, universities, CROs, and funding agencies.
Scientific & regulatory focus
SAPIOME blends microbiome and nutrition science with practical experience in clinical development, claims substantiation, and regulatory pathways for nutraceuticals and related biotech platforms.
About SAPIOME
SAPIOME was founded to bridge the gap between cutting-edge microbiome and nutrition research and the practical realities of product development, regulatory expectations, and commercial timelines.
If you have an upcoming milestone board meeting, funding round, trial design decision, or portfolio review—SAPIOME can help you sharpen the story and the science.
To minimize spam and ensure thoughtful outreach, the direct email address is revealed only after you confirm you are a real person.